Market Estimates
Valuation Metrics
Financials
Trading Trends
VYNE News & Events
Events Timeline

No data
News
People Also Watch
Frequently Asked Questions
What is Vyne Therapeutics Inc (VYNE) stock price today?
The current price of VYNE is 0.5619 USD — it has decreased -1.23 % in the last trading day.
What is Vyne Therapeutics Inc (VYNE)'s business?
VYNE Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat chronic inflammatory and immune-mediated conditions with high unmet need. Its lead program is repibresib gel (also known as VYN201), a topically administered, small-molecule pan-BD bromodomain and extra-terminal (BET) inhibitor designed as a soft drug to address diseases involving multiple, diverse inflammatory cell signaling pathways while providing low systemic exposure. Its second program is VYN202, an oral, small-molecule BD2-selective BET inhibitor. The Company has rights to research, develop and commercialize products containing BET inhibitor compounds for the treatment of any disease, disorder or condition in humans. Utilizing its InhiBET platform and through its preclinical and clinical activities, the Company is evaluating the impact that BET inhibitor compounds have on regulating pro-inflammatory cytokines.
What is the price predicton of VYNE Stock?
Wall Street analysts forecast VYNE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for VYNE is 2.00 USD with a low forecast of 2.00 USD and a high forecast of 2.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
What is Vyne Therapeutics Inc (VYNE)'s revenue for the last quarter?
Vyne Therapeutics Inc revenue for the last quarter amounts to 169.00K USD, increased 39.67 % YoY.
What is Vyne Therapeutics Inc (VYNE)'s earnings per share (EPS) for the last quarter?
Vyne Therapeutics Inc. EPS for the last quarter amounts to -0.17 USD, decreased -41.38 % YoY.
What changes have occurred in the market's expectations for Vyne Therapeutics Inc (VYNE)'s fundamentals?
How many employees does Vyne Therapeutics Inc (VYNE). have?
Vyne Therapeutics Inc (VYNE) has 13 emplpoyees as of January 09 2026.
What is Vyne Therapeutics Inc (VYNE) market cap?
Today VYNE has the market capitalization of 18.94M USD.



![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F20251221012213_31a24ca421f72f7a1da5ada25558397a.jpeg&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F20251219094204_459201d67e0ffc5796373c3aab215f2b.jpg&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F20251218054204_34a04269fdc1350b6b728d3125481968.jpg&w=384&q=75)